©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1995-2002
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1995
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1995
Table 1 Comparison of clinicopathological features between the recurrence group and non-recurrence group, n (%)
| Groups | Recurrence group (n = 69) | Non-recurrence group (n = 41) | t value | P value |
| Age (mean ± SD, yr) | 54.63 ± 15.58 | 55.10 ± 15.29 | ||
| Gender | 3.497 | 0.061 | ||
| Men | 40 (57.97) | 31 (75.61) | ||
| Female | 29 (42.03) | 10 (24.39) | ||
| HbsAg | 0.313 | 0.576 | ||
| Negative | 22 (31.88) | 11 (26.83) | ||
| Positive | 47 (68.12) | 30 (73.17) | ||
| TNM staging | 10.959 | 0.001 | ||
| Stage I-II | 28 (40.58) | 30 (73.17) | ||
| Stage III-IV | 41 (59.42) | 11 (26.83) | ||
| Tumor diameter | 0.979 | 0.323 | ||
| < 5 cm | 27 (39.13) | 20 (48.78) | ||
| ≥ 5 cm | 42 (60.87) | 21 (51.22) | ||
| Degree of tumor differentiation | 6.353 | 0.012 | ||
| Low differentiation | 30 (43.48) | 28 (68.29) | ||
| High differentiation | 39 (56.52) | 13 (31.71) | ||
| Lymph node metastasis | 5.208 | 0.022 | ||
| Yes | 30 (43.48) | 9 (21.95) | ||
| No | 39 (56.52) | 32 (78.05) | ||
| Number of tumors | 0.298 | 0.585 | ||
| Multiple | 44 (63.77) | 24 (58.54) | ||
| Single | 25 (36.23) | 17 (41.46) | ||
| Alpha-fetoprotein (μg/L) | 3.137 | 0.077 | ||
| < 200 | 37 (53.62) | 29 (70.73) | ||
| ≥ 200 | 32 (46.38) | 12 (29.27) |
- Citation: Hou JX, Wang YB, Wu J, Ding GS, Wu Y, Wei LH, Wang F, Zhang ZM. Clinical significance of serum oxidative stress and serum uric acid levels before surgery for hepatitis B-related liver cancer. World J Gastrointest Surg 2023; 15(9): 1995-2002
- URL: https://www.wjgnet.com/1948-9366/full/v15/i9/1995.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i9.1995